Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: Correlation with clinicopathological features
- Publication date
- 1 January 2018
- Publisher
- Universidad de Murcia. Departamento de Biología Celular e Histología